Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
7(54%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
8
62%
Ph early_phase_1
3
23%
Ph phase_3
2
15%

Phase Distribution

3

Early Stage

8

Mid Stage

2

Late Stage

Phase Distribution13 total trials
Early Phase 1First-in-human
3(23.1%)
Phase 2Efficacy & side effects
8(61.5%)
Phase 3Large-scale testing
2(15.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

7

trials recruiting

Total Trials

13

all time

Status Distribution
Active(12)
Completed(1)

Detailed Status

Not yet recruiting5
Recruiting5
Active, not recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
7
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 13 (23.1%)
Phase 28 (61.5%)
Phase 32 (15.4%)

Trials by Status

not_yet_recruiting538%
recruiting538%
active_not_recruiting215%
completed18%

Recent Activity

7 active trials
Showing 5 of 13
active_not_recruitingphase_2

PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)

NCT06853912
not_yet_recruitingphase_2

Psilocybin Therapy for Methamphetamine Use Disorder and HIV

NCT07756736
recruitingphase_2

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

NCT06518720
recruitingphase_2

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

NCT06512220
active_not_recruitingphase_3

Psilocybin for Major Depressive Disorder (MDD)

NCT06308653
View all 13 trials

Clinical Trials (13)

Showing 13 of 13 trials
NCT06853912Phase 2

PsiloStudy: Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcohol Use Disorder (AUD)

Active Not Recruiting
NCT07756736Phase 2

Psilocybin Therapy for Methamphetamine Use Disorder and HIV

Not Yet Recruiting
NCT06518720Phase 2

Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND)

Recruiting
NCT06512220Phase 2

Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)

Recruiting
NCT06308653Phase 3

Psilocybin for Major Depressive Disorder (MDD)

Active Not Recruiting
NCT07306364Phase 2

Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain

Not Yet Recruiting
NCT06902974Phase 2

Psilocybin-Assisted Therapy for Sexual Assault-Related PTSD

Recruiting
NCT06724289Early Phase 1

Psilocybin for Prolonged Grief Disorder

Recruiting
NCT05710237Phase 2

Does Psilocybin Require Psychedelic Effects to Treat Depression?

Completed
NCT06943573Phase 3

Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder

Not Yet Recruiting
NCT06760533Early Phase 1

Psilocybin-Assisted Psychotherapy in Treating Irritable Bowel Syndrome (IBS)

Not Yet Recruiting
NCT07405606Phase 2

Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder

Not Yet Recruiting
NCT06899594Early Phase 1

Psilocybin for Methamphetamine Addiction

Recruiting

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13